about
The ongoing history of thermal therapy for cancerRadiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticlesReplacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines.A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction.Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts.Metastatic VIPoma presenting as an ovarian massAortoiliac aneurysm repair in kidney transplant recipients.Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology.Living donor renal transplant recipients tolerate early removal of bladder catheters.Cadaveric renal transplant recipients can safely tolerate removal of bladder catheters within 48 h of transplant.Asymptomatic lower extremity acrocyanosis: report of two cases and review of the literature.Current approaches to cutaneous sarcomas: Dermatofibrosarcoma protuberans and cutaneous leiomyosarcoma.Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions.TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.Impact of body mass index on the short-term outcomes of resected gastrointestinal stromal tumors.Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles.Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.A protocol to effectively create single cell suspensions of adherent cells for multiparameter high-throughput flow cytometry.Predictors and implications of unplanned conversion during minimally invasive hepatectomy: an analysis of the ACS-NSQIP database.Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma.Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model.A comparison of unguided vs guided case-based instruction on the surgery clerkship.Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases.Better Late than Never? Adherence to Adjuvant Therapy Guidelines for Stage III Colon Cancer in an Underserved Region.Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases.Molecular Alterations Associated with DNA Repair in Pancreatic Adenocarcinoma Are Associated with Sites of Recurrence.Recognition of complications after pancreaticoduodenectomy for cancer determines inpatient mortality.IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma.Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I diseaseComprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinomaThe impact of race and socioeconomic status on the presentation, management and outcomes for gastric cancer patients: Analysis from a metropolitan area in the southeast United StatesTGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
P50
Q30469171-34835AC5-75D9-4943-8435-27C16A3915C9Q33610377-D5F6A1E3-C42A-4572-94B9-D93E8080F5AAQ33742306-3067538F-3078-4EA7-9A3C-7131D6DA38A9Q33953987-B4845ACA-DE31-4FC9-A64E-F82A1054403CQ35015474-5BFDA40E-5702-4E1E-AEDB-92038736D773Q36431695-95518AD3-F095-48A1-A1EF-9697243E7077Q37321797-215EE6CB-A0E6-4215-872A-E8CACA5E5495Q37373098-3A22180C-E563-49AC-8C53-6BC808F9D7F4Q37429131-E86B4895-EFDB-4CD2-87C4-EBB36DD50287Q37429135-E53F60A4-4F9C-4D7C-B2BD-1E23939BB924Q37864847-A4DE4907-4BB5-473B-87B6-4CB3416C29F8Q38567177-57E80CE1-E057-4BBE-B231-10443C8145EAQ39094558-A98F8B7F-6D6A-444E-B051-9D614FDD5612Q39147303-759FA620-6122-457F-95EE-1332B99D16DDQ39360280-88E2E762-AC3B-4CE3-BF37-729D404DBA3AQ39694145-9E4E3D82-8438-4B15-A904-445AA290B5A2Q39704277-2847CE14-F00A-4B7B-A388-74E07BC09109Q39765251-4761D192-5905-4E90-A811-A4B8FED595FFQ40112753-23D0BBA6-D0F6-44CA-8479-63A7E57D5513Q40398898-6BF959A8-0987-4839-93D6-A0B9C92DA12CQ40510647-DD62262E-724E-4BA0-B9BE-3EE88CB206BDQ41940569-FE43D000-EA57-4D92-9E4D-20EE078CB7A6Q44195408-C987D7B7-7579-4C3B-BFF4-479E565C6A32Q44371230-92B34608-D647-4E10-9F66-359BD71E10FAQ47627901-EA155D5C-60A1-4EA2-939C-4831F3CB680FQ48065839-C0C6873A-11A1-4732-9A56-2F483E4DD399Q50089892-3E077F09-64C8-4D83-8809-48C467073053Q50710274-AF95AAEF-C407-4F9E-B8D5-94D9C327E863Q52719969-3723E5FA-D307-45F2-9018-F4853C39F1DAQ57118434-04B18241-6A52-4D7D-A366-9BA60D3AEFD8Q90289571-D54DD2AE-910F-41FE-8ABC-A2685A5B3285Q92418356-52F203B4-C111-477E-895F-141F8B146CCDQ92494115-68923EC6-098B-42B6-856F-EF24A9BCA39F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Evan S Glazer
@en
Evan S Glazer
@nl
type
label
Evan S Glazer
@en
Evan S Glazer
@nl
prefLabel
Evan S Glazer
@en
Evan S Glazer
@nl
P108
P31
P496
0000-0002-5796-0542